Site Search
Site Search
IHI is a public-private partnership (PPP) between the EU and Europe’s health industries.
This online event focused on how Innovative Medicines Initiative (IMI) projects are delivering results to advance the development and uptake of Ebola vaccines.

EBOVAC2 received a special jury prize at the Étoiles de l'Europe awards for studies on the safety and immunogenicity of the Janssen vaccine in young, old, and HIV-infected people.

RESCEU have put together the most comprehensive cache of evidence to date on the true burden of a disease that still claims millions of mostly infant victims every year

VAC2VAC provided vital evidence to demonstrate that non-animal alternatives can reliably detect certain contaminants in medicines administered by injection.